Role of Nitric Oxide in the Skeletal Muscle Vascular Bed

  • Hunter C. Champion
  • Philip J. Kadowitz
Part of the Nitric Oxide in Biology and Medicine book series (NOBM, volume 1)

Abstract

Nitric oxide (NO) is a free radical synthesized by NO synthase (NOS), an enzyme that exists in three identified isoforms in the body (Kerwin et al. 1995). The isoforms of NOS have been named on the basis of location: neural constitutive NOS (type I or nNOS), inducible NOS (type II or iNOS), and endothelial constitutive NOS (type III or eNOS) (Kerwin et al. 1995). Although all forms are distinct based on their location, each form uses L-arginine in the formation of NO in a reaction that requires molecular oxygen and NADPH as cosubstrates with L-citrulline produced as a by-product of the reaction. NOS types I, II, and III are found in the skeletal muscle vascular bed, with types I and III being found under physiological conditions, and the mRNA for type II NOS being up-regulated under pathophysiological conditions, such as in gram-negative sepsis (Kerwin et al. 1995; Reid 1998).

Keywords

Nitric Oxide Reactive Hyperemia Vasodilator Response Soluble Guanylate Cyclase Reactive Hyperemic Response 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bellan JA, Minkes RK, McNamara DB, & Kadowitz PJ, 1991. N M-Nitro-L-arginine selectively inhibits vasodilator responses to acetylcholine and bradykinin in cats. Am J Physiol 260:111125–HU29.Google Scholar
  2. Bellan JA, McNamara DB, & Kadowitz PJ, 1993. Differential effects of nitric oxide synthesis inhibitors on vascular resistance and responses on cats. Am J Physiol 264:H45–H52.PubMedGoogle Scholar
  3. Champion HC, & Kadowitz PJ, 1997. Vasodilator responses to acetylcholine, bradykinin, and substance P are mediated by a TEA-sensitive mechanism. Am J Physiol 272:R44–R422.Google Scholar
  4. Champion HC, & Kadowitz PJ, 1997. Nitric oxide release and the opening of K+ATP channels mediate vasodilator responses to histamine in the hindlimb vascular bed of the cat. Am J Physiol 273:H928–H937.PubMedGoogle Scholar
  5. Champion HC, & Kadowitz PJ, 1998. [D-Ala2]-Endomorphin 2(TAPP) has novel endothelium-dependent vasodilator activity in the rat. Am J Physiol 274:H1690–H1697.PubMedGoogle Scholar
  6. Champion HC, Murphy WA, Coy DH, & Kadowitz PJ, 1997a. Proadrenomedullin NH2-terminal peptide, a product of the adrenomedullin gene, has direct vasodilator activity in the cat. Am J Physiol 272:R1047–R1054.PubMedGoogle Scholar
  7. Champion HC, Santiago JA, Murphy WA, Coy DH, & Kadowitz PJ, 1997b. Adrenomedullin(22-52) antagonizes vasodilator responses to calcitonin gene-related peptide but not adrenomedullin in the cat. Am J Physiol 272:R234–R243.PubMedGoogle Scholar
  8. De Witt BJ, Cheng DY, & Kadowitz PJ, 1994. Des-arg9-bradykinin produces tone-dependent kinin ß l-receptor-mediated responses in the pulmonary vascular bed. Circ Res 75:1064–1072.CrossRefGoogle Scholar
  9. De Witt BJ, Cheng DY, McMahon TJ, Marrone JR, Champion HC, & Kadowitz PJ, 1996. Differential effects of U-37883A, a novel KATp channel antagonist, in the pulmonary and hindlimb vascular beds of the cat. Am J Physiol 271.L924–L931.Google Scholar
  10. De Witt BJ, Champion HC, Marrone JR, McNamara DB, Giles TD, Greenberg SS, & Kadowitz PJ, 1997. Differential effects of L-N 5-(l-iminoethyl) ornithine on tone and endothelium-dependent vasodilator responses. Am J Physiol 272.L588–L594.Google Scholar
  11. Feng CJ, Kang B, Kaye AD, Kadowitz PJ, & Nossaman BD, 1994. L-NAME modulates responses to adrenomedullin in the hindquarters vascular bed of the cat. Life Sci 55:PL433–538.Google Scholar
  12. Furchgott RF, 1983. Role of endothelium in responses of vascular smooth muscle. Circ. Res. 53:551–513.CrossRefGoogle Scholar
  13. Furchgott RF, & Zawadzki JV, 1980. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373–316.PubMedCrossRefGoogle Scholar
  14. Ignarro LJ, 1990. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol 30:535–560.PubMedCrossRefGoogle Scholar
  15. Joyner MJ, & Dietz NM, 1997. Nitric oxide and vasodilation in human limbs. J. Appl Physio 83:1785–1196.Google Scholar
  16. Kerwin JF, Lancaster JR, & Feldman PL, 1995. Nitric oxide: a new paradigm for second messengers. J Med Chem 38:4343–4360.PubMedCrossRefGoogle Scholar
  17. Lincoln TM, 1989. Cyclic GMP and mechanisms of vasodilation. Pharmacol Ther 41:419–502.CrossRefGoogle Scholar
  18. Majid DSA, & Navar LG, 1992. Suppression of blood flow autoregulation plateau during nitric oxide blockade in canine kidney. Am J Physiol 262:F40–F46.PubMedGoogle Scholar
  19. Majid DSA, Williams A, & Navar LG. 1992. Effect of DuP 753 on renal responses to endothelium-derived nitric oxide (EDNO) inhibition in dogs. FASEB J. 6.A1511.Google Scholar
  20. Majid DSA, Kadowitz PJ, Coy DH, & Navar LG. 1996. Renal responses to intra-arterial administration of adrenomedullin in dogs. Am J Physiol 270:F200–F205.PubMedGoogle Scholar
  21. McMahon TJ, & Kadowitz PJ. 1993. Analysis of pulmonary vascular responses to substance P in the cat. Am J Physiol 267.H394–H402.Google Scholar
  22. Minkes RK, McMahon TJ, & Kadowitz PJ. 1995. Role of K+ATP channels and endothelium-derived relaxing factor in reactive hyperemia in the hindquarters vascular bed of the cat. Am J Physiol 269:1704–1712.Google Scholar
  23. Moncada S, Gryglewski RJ, Bunting S, & Vane JR. 1976. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature (Lond.) 263:663–665.CrossRefGoogle Scholar
  24. Neely CF, Matot L, Haile D, Nguyen J, & Batra V. 1995. Tone-dependent responses to his-tamine in feline pulmonary vascular bed. Am J Physiol 268.H653–H661.PubMedGoogle Scholar
  25. Nossaman BD, Feng CJ, & Kadowitz PJ. 1994. Analysis of responses to bradykinin and influence of HOE 140 in the isolated perfused rat lung. Am J Physiol 266: H2452–H2461.PubMedGoogle Scholar
  26. Nossaman BD, Feng CJ, Kaye AD, De Witt BJ, Coy DH, Murphy WA, & Kadowitz PJ. 1996. Pulmonary vasodilator responses to adrenomedullin are reduced by nitric oxide synthase inhibitors in rats but not in cats. Am J Physiol 270.L782–L789.PubMedGoogle Scholar
  27. Pucci ML, Lin L, & Nasjletti A. 1992. Pressor and renal vasoconstrictor effects of N G-nitro-L-arginine as affected by blockade of pressor mechanisms mediated by the sympathetic nervous system, angiotensin, prostanoids, and vasopressin. J Pharmacol Exp Ther 261:240–245.PubMedGoogle Scholar
  28. Regoli D, & Barabe J. 1980. Pharmacology of bradykinin and related kinins. Pharmacol Rev 32:1–46.PubMedGoogle Scholar
  29. Regoli D, Rahaleb N-E, Dion S, & Drapeau G. 1990. New selective bradykinin receptor antagonists and bradykinin B2 receptor characterization. Trends Pharmacol Sci 77:156–161.CrossRefGoogle Scholar
  30. Reid MB. 1998. Role of nitric oxide in skeletal muscle: synthesis, distribution and functional importance. Acta Physiol Scand. 162:401–409.PubMedCrossRefGoogle Scholar
  31. Santiago JA, Garrison EA, & Kadowitz PJ. 1994. Analysis of responses to bradykinin: effect of Hoe 140 in the hindquarters vascular bed of the cat. Am J Physiol 267:H828–H836.PubMedGoogle Scholar
  32. Santiago JA, Garrison EA, Champion HC, Smith RE, Del Rio O, & Kadowitz PJ. 1995. Analysis of responses to kallidin, DABK, and DAK in feline hindlimb vascular bed. Am J Physiol 269:H2057–H2064.PubMedGoogle Scholar
  33. Santiago JA, Champion HC, & Kadowitz PJ. 1997. T-kinin has endothelial-dependent vasodilator activity in the cat. Am J Physiol 272.H1491–H1498.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2000

Authors and Affiliations

  • Hunter C. Champion
  • Philip J. Kadowitz

There are no affiliations available

Personalised recommendations